{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:07Z","timestamp":1707524947057},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,12]]},"DOI":"10.7759\/cureus.34886","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T08:46:05Z","timestamp":1676191565000},"source":"Crossref","is-referenced-by-count":0,"title":["The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report"],"prefix":"10.7759","author":[{"given":"Theofilos","family":"Tsoleridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S10371","article-title":"Post-herpetic neuralgia","volume":"5","author":"Tontodonati M","year":"2012","unstructured":"Tontodonati M, Ursini T, Polilli E, Vadini F, Di Masi F, Volpone D, Parruti G. Post-herpetic neuralgia. Int J Gen Med. 2012, 5:861-71. 10.2147\/IJGM.S10371","journal-title":"Int J Gen Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002%2F14651858.CD012227.pub2","article-title":"Paracetamol with or without codeine or dihydrocodeine for neuropathic pain in adults","volume":"12","author":"Wiffen PJ","year":"2016","unstructured":"Wiffen PJ, Knaggs R, Derry S, Cole P, Phillips T, Moore RA. Paracetamol with or without codeine or dihydrocodeine for neuropathic pain in adults. Cochrane Database Syst Rev. 2016, 12:CD012227. 10.1002%2F14651858.CD012227.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002%2F14651858.CD004846.pub3","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia","volume":"2013","author":"Khaliq W","year":"2013","unstructured":"Khaliq W, Alam S, Puri NK. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2013, 2013:004846. 10.1002%2F14651858.CD004846.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.182","article-title":"Qutenza\u00ae: a capsaicin 8% patch for the management of postherpetic neuralgia","volume":"11","author":"Wallace M","year":"2011","unstructured":"Wallace M, Pappagallo M. Qutenza\u00ae: a capsaicin 8% patch for the management of postherpetic neuralgia. Expert Rev Neurother. 2011, 11:15-27. 10.1586\/ern.10.182","journal-title":"Expert Rev Neurother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011669.pub2","article-title":"Morphine for chronic neuropathic pain in adults","volume":"5","author":"Cooper TE","year":"2017","unstructured":"Cooper TE, Chen J, Wiffen PJ, et al.. Morphine for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017, 5:CD011669. 10.1002\/14651858.CD011669.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200822050-00005","article-title":"An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy","volume":"22","author":"Zin CS","year":"2008","unstructured":"Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs. 2008, 22:417-42. 10.2165\/00023210-200822050-00005","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1503%2Fcmaj.101409","article-title":"Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia. In: Herpes Zoster and Postherpetic Neuralgia, pp. 39-64","author":"Dworkin RH","year":"2001","unstructured":"Dworkin RH, Schmader KE. Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia. In: Herpes Zoster and Postherpetic Neuralgia, pp. 39-64.  Watson CPN, Gershon AA (ed): Elsevier, New York, NY; 2001. 10.1503%2Fcmaj.101409"},{"key":"ref8","article-title":"Transdermal buprenorphine in the management of persistent pain - safety aspects","volume":"2","author":"Likar R","year":"2006","unstructured":"Likar R. Transdermal buprenorphine in the management of persistent pain - safety aspects. Ther Clin Risk Manag. 2006, 2:115-25.","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","article-title":"Opioids and neuropathic pain","volume":"15","author":"Smith HS","year":"2012","unstructured":"Smith HS. Opioids and neuropathic pain. Pain Physician. 2012, 15:ES93-110.","journal-title":"Pain Physician"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147%2FTCRM.S47138","article-title":"Options for treating postherpetic neuralgia in the medically complicated patient","volume":"9","author":"Bruckenthal P","year":"2013","unstructured":"Bruckenthal P, Barkin RL. Options for treating postherpetic neuralgia in the medically complicated patient. Ther Clin Risk Manag. 2013, 9:329-40. 10.2147%2FTCRM.S47138","journal-title":"Ther Clin Risk Manag"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.1.6.729","article-title":"Transdermal buprenorphine in chronic pain: indications and clinical experience","volume":"1","author":"Kusnik S","year":"2008","unstructured":"Kusnik S, Likar R, Sittl R. Transdermal buprenorphine in chronic pain: indications and clinical experience. Expert Rev Clin Pharmacol. 2008, 1:729-36. 10.1586\/17512433.1.6.729","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.5.3.315","article-title":"Transdermal buprenorphine in the treatment of chronic pain","volume":"5","author":"Sittl R","year":"2005","unstructured":"Sittl R. Transdermal buprenorphine in the treatment of chronic pain. Expert Rev Neurother. 2005, 5:315-23. 10.1586\/14737175.5.3.315","journal-title":"Expert Rev Neurother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002%2F14651858.CD011603.pub2","article-title":"Buprenorphine for neuropathic pain in adults","volume":"2015","author":"Wiffen PJ","unstructured":"Wiffen PJ, Derry S, Moore RA, et al.. Buprenorphine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015:CD011603. 10.1002%2F14651858.CD011603.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.678938","article-title":"Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain","volume":"28","author":"Wolff RF","year":"2012","unstructured":"Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin. 2012, 28:833-45. 10.1185\/03007995.2012.678938","journal-title":"Curr Med Res Opin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/16327.6917","article-title":"Comparison between transdermal buprenorphine and transdermal fentanyl for postoperative pain relief after major abdominal surgeries","volume":"9","author":"Arshad Z","year":"2015","unstructured":"Arshad Z, Prakash R, Gautam S, Kumar S. Comparison between transdermal buprenorphine and transdermal fentanyl for postoperative pain relief after major abdominal surgeries. J Clin Diagn Res. 2015, 9:UC01-4. 10.7860\/JCDR\/2015\/16327.6917","journal-title":"J Clin Diagn Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241362","article-title":"Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block","volume":"15","author":"Tran PN","year":"2020","unstructured":"Tran PN, Sheng J, Randolph AL, et al.. Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. PLoS One. 2020, 15:e0241362. 10.1371\/journal.pone.0241362","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118656-the-use-of-transdermal-buprenorphine-for-acute-postherpetic-neuralgia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:01Z","timestamp":1707508741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118656-the-use-of-transdermal-buprenorphine-for-acute-postherpetic-neuralgia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.34886","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,12]]}}}